Skip to main content

Phenylketonuria

  • Reference work entry
  • First Online:
  • 20 Accesses

Synonyms

Følling’s disease; Hyperphenylalaninemia; Imbecillitas phenylpyrouvica; Oligophrenia phenylpyruvia; PKU

Definition

Phenylketonuria (PKU) is a rare autosomal recessive condition characterized by an inability to metabolize the amino acid phenylalanine. The most common variation of PKU is associated with a mutation of the phenylalanine hydroxylase (PAH) gene, located on chromosome 12q. Individuals with PKU have an absence of or significant deficiency in the PAH enzyme. Functional PAH is necessary for the metabolism of phenylalanine into tyrosine, a precursor for the neurotransmitter dopamine. Disruption of this metabolic process results in higher-than-normal levels of phenylalanine as well as decreased tyrosine levels. The excessive phenylalanine further competes with the available tyrosine and other large neutral amino acids (LNAAs) to cross the blood-brain barrier, ultimately resulting in decreased synthesis of dopamine and other neurotransmitters within the brain.

Related...

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References and Readings

  • Blau, N. (Ed.). (2006). PKU and BH4: Advances in phenylketonuria and tetrahydrobiopterin. Heilbronn: SPS.

    Google Scholar 

  • Christ, S. E. (2003). Asbjørn Følling and the discovery of phenylketonuria. Journal of the History of the Neurosciences, 12, 44–54.

    Article  PubMed  Google Scholar 

  • National Institutes of Health Consensus Development Panel. (2001). National Institutes of Health consensus development conference statement: Phenylketonuria: Screening and management, October 16-18, 2000. Pediatrics, 108, 972–982.

    Article  Google Scholar 

  • Welsh, M. C., Pennington, B. F., Ozonoff, S., Rouse, B., & McCabe, E. R. R. (1990). Neuropsychology of early-treated phenylketonuria: Specific executive function deficits. Child Development, 61, 1697–1713.

    Article  PubMed  Google Scholar 

  • Al Hafid, N., & Christodoulou, J. (2015). Phenylketonuria: A review of current and future directions. Translational Pediatrics, 4(4), 304–317.

    PubMed Central  PubMed  Google Scholar 

  • Camo, K., Parisi, M., Acosta, P., Berry, G., Bilder, D., Blau, N., et al. (2014). Phenylketonuria scientific review conference: State of the science and future research needs. Molecular Genetics and Metabolism, 112(2), 87–122.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shawn E. Christ .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Christ, S.E. (2018). Phenylketonuria. In: Kreutzer, J.S., DeLuca, J., Caplan, B. (eds) Encyclopedia of Clinical Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-319-57111-9_1586

Download citation

Publish with us

Policies and ethics